UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000030457 |
|---|---|
| Receipt number | R000034774 |
| Scientific Title | Phase II trial of early secondary treatment with nibolumab for non-small cell lung cancer |
| Date of disclosure of the study information | 2018/01/01 |
| Last modified on | 2021/06/21 14:17:02 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2017/12/18 21:30:07 | ||
| 2 | Update | 2019/12/20 12:54:51 | Interventions/Control_1 |
|
| 3 | Update | 2019/12/20 12:57:49 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Organization Zip code Last name of contact person Last name of contact person Organization Zip code Organization Institute Organization Organization Organization Address Address Tel |
|
| 4 | Update | 2019/12/20 13:01:47 | Date of IRB Last follow-up date |
|
| 5 | Update | 2020/06/20 09:02:52 | ||
| 6 | Update | 2021/06/21 14:17:02 | Recruitment status |
